BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 19944975)

  • 21. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
    Sonabend AM; Dana K; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of local immunoresistance in glioma.
    Albesiano E; Han JE; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas.
    Barzon L; Zanusso M; Colombo F; Palù G
    Cancer Gene Ther; 2006 Jun; 13(6):539-54. PubMed ID: 16410822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell immunotherapy for malignant glioma: toward a combined approach.
    Dietrich PY; Dutoit V; Tran Thang NN; Walker PR
    Curr Opin Oncol; 2010 Nov; 22(6):604-10. PubMed ID: 20739889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular immunity in the treatment of brain tumors.
    Wheeler CJ; Yu JS; Black KL
    Clin Neurosurg; 2004; 51():132-9. PubMed ID: 15571138
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials in cellular immunotherapy for brain/CNS tumors.
    Badhiwala J; Decker WK; Berens ME; Bhardwaj RD
    Expert Rev Neurother; 2013 Apr; 13(4):405-24. PubMed ID: 23545055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cells as vehicles for the treatment of brain cancer.
    Mapara KY; Stevenson CB; Thompson RC; Ehtesham M
    Neurosurg Clin N Am; 2007 Jan; 18(1):71-80, ix. PubMed ID: 17244555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic strategies for brain tumor therapy.
    Lawler SE; Peruzzi PP; Chiocca EA
    Cancer Gene Ther; 2006 Mar; 13(3):225-33. PubMed ID: 16138122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
    Janelidze S; Bexell D; Badn W; Darabi A; Smith KE; Fritzell S; Gunnarsson S; Milos P; Bengzon J; Salford LG; Siesjö P; Visse E
    J Immunother; 2009; 32(6):593-601. PubMed ID: 19483650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in gene therapy and immunotherapy for brain tumors.
    Kew Y; Levin VA
    Curr Opin Neurol; 2003 Dec; 16(6):665-70. PubMed ID: 14624074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring immune responses after glioma vaccine immunotherapy.
    Jian B; Yang I; Parsa AT
    Neurosurg Clin N Am; 2010 Jan; 21(1):195-9. PubMed ID: 19944978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Peptide vaccination therapy for malignant glioma].
    Yamanaka R; Itoh K
    Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for glioblastoma.
    Aghi M; Chiocca EA
    Neurosurg Focus; 2006 Apr; 20(4):E18. PubMed ID: 16709023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passive antibody-mediated immunotherapy for the treatment of malignant gliomas.
    Mitra S; Li G; Harsh GR
    Neurosurg Clin N Am; 2010 Jan; 21(1):67-76. PubMed ID: 19944967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral vaccines for cancer immunotherapy.
    Eisenberger A; Elliott BM; Kaufman HL
    Hematol Oncol Clin North Am; 2006 Jun; 20(3):661-87. PubMed ID: 16762729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gliomas: new ways of treatment?
    van Acker RE
    Clin Neurol Neurosurg; 1977; 80(2):112-5. PubMed ID: 209922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic viral therapy and immunotherapy of malignant brain tumors: two potential new approaches of translational research.
    Lou E
    Ann Med; 2004; 36(1):2-8. PubMed ID: 15000342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses.
    Ikeda K; Ichikawa T; Wakimoto H; Silver JS; Deisboeck TS; Finkelstein D; Harsh GR; Louis DN; Bartus RT; Hochberg FH; Chiocca EA
    Nat Med; 1999 Aug; 5(8):881-7. PubMed ID: 10426310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune and viral therapies for malignant primary brain tumors.
    Gardeck AM; Sheehan J; Low WC
    Expert Opin Biol Ther; 2017 Apr; 17(4):457-474. PubMed ID: 28274139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurosurgery and molecular biology: (series 12) immunological therapy for gliomas].
    Kijima H; Shimizu K
    No Shinkei Geka; 1999 Dec; 27(12):1071-7. PubMed ID: 10629887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.